Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1978 of 5804
-
Sugar-Free diet may shield hispanic kids from fatty liver
Prevention TerminatedThis is a 2 year clinical trial testing an intensive intervention to reduce dietary sugars as a means to prevent non-alcoholic fatty liver disease (NAFLD) in pre-pubertal Hispanic children.
Phase: NA • Sponsor: Emory University • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New study tracks COVID-19 vaccine side effects in kids ages 5 to 16
Knowledge-focused CompletedThis is a prospective, observational study. During the study, children and adolescents (ages ≥ 5 to \< 16) will be followed post administration of mRNA COVID-19 vaccines. Injection site (local), systemic reaction, and unsolicited adverse event data will be assessed on vaccinatio…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Which sedative is safer for emergency intubation? large trial seeks answers
Disease control CompletedAmong critically ill adults undergoing emergency tracheal intubation, one in five experience hypotension, cardiac arrest, or death. The sedatives used to rapidly induce anesthesia for emergency tracheal intubation have been hypothesized to effect cardiovascular complications and …
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for brain metastases? drug niraparib tested in small trial
Disease control OngoingThis research is being done to see how effective the drug niraparib is against cancer that has metastasized to the central nervous system (CNS). * This research study involves the study drug niraparib.
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Tailored diet app beats One-Size-Fits-All advice in heart health showdown
Disease control CompletedThe ZOE Method Study will test the efficacy of personalized nutritional advice, delivered on an individual level through a digital device app; integrating dietary, lifestyle, physiological and metagenomic data, in improving certain cardiometabolic disease risk factors, compared t…
Phase: NA • Sponsor: Zoe Global Limited • Aim: Disease control
Last updated Jun 26, 2026 14:44 UTC
-
Can a Video-Based diet and exercise program help veterans with sleep apnea shed pounds and sleep better?
Disease control CompletedPrevalent obesity related conditions like obstructive sleep apnea (OSA) represent an important opportunity to improve population health. OSA reduces quality of life and is associated with greater risk for cardiovascular disease. Although obesity is the single greatest reversible …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Smart dosing of antibiotics may cut infection risk after colon surgery
Prevention CompletedPreoperative antimicrobial prophylaxis is a key element for the prevention of surgical site infection, the most common type of nosocomial infection in surgical patients. Prophylactic antibiotics are selected depending on the type of surgery, and first- or second-generation cephal…
Phase: NA • Sponsor: Asan Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
New antibody AU-007 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis is a first in human, open-label, multi-center Phase 1 / 2 study to evaluate the safety, tolerability, and initial efficacy of AU-007, also known as imneskibart, in patients with advanced solid tumors. AU-007 will be administered either as a monotherapy, or in combination wit…
Phase: PHASE1, PHASE2 • Sponsor: Aulos Bioscience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Cancer-Fighting super cells tested in solid tumors – study halted early
Disease control TerminatedA Phase I/II study of autologous T cells engineered using the Sleeping Beauty transposon/transposase system to express TCR(s) reactive against neoantigens in subjects with relapsed/refractory solid tumors
Phase: PHASE1, PHASE2 • Sponsor: Alaunos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Brain zapping therapy shows promise for PTSD in new trial
Symptom relief CompletedThe purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder
Phase: NA • Sponsor: Wave Neuroscience • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can soul food makeover cut diabetes risk? new study tests culturally relevant diets
Disease control OngoingBased on the findings of our formative work, conduct a one-year intervention among African American Adults using revised culturally tailored materials to examine differences in Healthy Eating Index (HEI) and type 2 diabetes (T2DM) risk factors among participants (n=198) randomize…
Phase: NA • Sponsor: University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Shocking weight loss? Ear-Zapping device tested for obesity
Disease control OngoingTranscutaneous vagus nerve stimulation (TENS) involves stimulation of the left and/or right auricular branch of the vagus nerve with low-frequency electrical impulses. In recent years, the possibilities of using this technology in chronic conditions characterized by immune and me…
Phase: NA • Sponsor: National Medical Research Center for Therapy and Preventive Medicine • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC
-
Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
Disease control CompletedTo assess the impact of SQ SLIT-tablets (SQ Grass SLIT-tablet and SQ HDM SLIT-tablet) in Danish and Swedish allergic rhinitis (AR) patients, with or without asthma, between 2007-2020.
Sponsor: ALK-Abelló A/S • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Real-World study tests daily pill for diabetes control
Disease control CompletedThe purpose of the study is to collect information on how Rybelsus® works in people with type 2 diabetes and to see if Rybelsus® can lower their blood sugar levels. Participants will get Rybelsus® as prescribed to them by the study doctor. The study will last for about 8-10 month…
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Scientists probe Brain's social wiring to tackle depression
Knowledge-focused Recruiting nowThe overall goal of this study is to map the spatiotemporal dynamics of social affective processing and to examine selective modulation of these dynamics in humans undergoing invasive intracranial monitoring for treatment-resistant epilepsy and depression. Pursuing this signal fr…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Michigan study tests After-School program to curb youth violence
Prevention Recruiting nowThe purpose of this study is to evaluate the efficacy of YES-IDEAS (YES: Innovative Discussion for Engagement, Achievement, and Service)compared to regular after school programming in increasing youth empowerment, promoting positive behaviors, and decreasing youth violence. Thro…
Phase: NA • Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
New oral drug MRX-2843 tested in Hard-to-Treat leukemias
Disease control Recruiting nowThis is a Phase I, open-label, non-randomized, dose escalation study in adolescents and adults with relapsed/refractory acute myeloid leukemia, acute lymphoblastic leukemia, or mixed phenotype acute leukemia. Patients will receive continuous oral MRX-2843 in 28 day cycles at pred…
Phase: PHASE1 • Sponsor: Meryx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hormone treatment shows promise for rare adrenal disorder
Disease control CompletedThis phase III study is an open-label extension study to be conducted at approximately 21 investigational sites across 3 countries. The study will evaluate the long-term safety and tolerability of Chronocort in participants aged 16 years and over when used as treatment for Congen…
Phase: PHASE3 • Sponsor: Immedica Pharma AB • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a simple blood test catch Alzheimer's before symptoms start?
Knowledge-focused Recruiting nowThis research study aims to examine biomarkers of Alzheimer's disease (AD) as early as possible which could potentially be a screening tool for the general population. This observational study will take place at the Skåne University Hospital in Sweden. The study will enroll up to…
Sponsor: Skane University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Brain scans reveal hidden links between depression, cannabis, and HIV in young adults
Knowledge-focused Recruiting nowTo elucidate mechanisms of substance use disorders (SUD) and comorbid mental illnesses in people living with HIV (PLWH), the study team seeks to investigate reward and pain circuitry in cannabis use and depression comorbidity, two highly prevalent conditions in PLWH. The study te…
Phase: NA • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC